Prostate Cancer - Results from #180

Digital Pathology-based Artificial Intelligence Biomarker Validation in Metastatic Prostate Cancer. December 16, 2024

Prognostic value of baseline alkaline phosphatase of 177Lu-PSMA radioligand therapy in metastatic castration-resistant prostate cancer: A systematic review and meta-analysis. December 16, 2024

Recent Patterns and Trends in Global Prostate Cancer Incidence and Mortality: An Update. December 16, 2024

Assessing the Molecular Heterogeneity of Prostate Cancer Biopsy Sampling: Insights from the MAST Trial. December 16, 2024

Castrate-resistant prostate cancer response to taxane is determined by an HNF1-dependent apoptosis resistance circuit. December 13, 2024

Stress testing deep learning models for prostate cancer detection on biopsies and surgical specimens. December 13, 2024

Histopathologic Features and Transcriptomic Signatures Do Not Solve the Issue of Magnetic Resonance Imaging-Invisible Prostate Cancers: A Matched-Pair Analysis. December 13, 2024

AR alterations inform circulating tumor DNA detection in metastatic castration resistant prostate cancer patients. December 13, 2024

Etiology of prostate cancer with the TMPRSS2:ERG fusion: A systematic review of risk factors. December 13, 2024

Racial Disparities in Future Development of Lethal Prostate Cancer Based on Midlife Baseline Prostate-Specific Antigen. December 12, 2024

Impact of Discordance Between MRI and US Volume Measurements on Prostate Fusion Biopsy Outcomes. December 12, 2024

How Prostate Cancer Growth Patterns Impact Detection and Interreader Agreement on Multiparametric MRI. December 12, 2024

Minimizing infectious complications following transrectal prostate biopsy: a proposal for a risk-adapted antibiotic treatment strategy with Ceftriaxone and Ertapenem as key components. December 12, 2024

Late radiation-related lymphopenia after prostate stereotactic body radiation therapy plus or minus supplemental pelvic irradiation. December 12, 2024

Baseline Nodal Status on 68Ga-PSMA-11 Positron Emission Tomography/Computed Tomography in Men with Intermediate- to High-risk Prostate Cancer Is Prognostic for Treatment Failure: Follow-up of the proPSMA Trial. December 11, 2024

ERG and PTEN Role on Active Surveillance for Low-Risk Prostate Cancer in the Multiparametric MRI Era. December 11, 2024

Physician Reasons for or Against Treatment Intensification in Patients With Metastatic Prostate Cancer. December 11, 2024

A Prostate Imaging-Reporting and Data System version 2.1-based predictive model for clinically significant prostate cancer diagnosis. December 11, 2024

Plasma cell-free DNA chromatin immunoprecipitation profiling depicts phenotypic and clinical heterogeneity in advanced prostate cancer. December 11, 2024

Androgen receptor inhibition increases MHC Class I expression and improves immune response in prostate cancer. December 11, 2024

Page 10 of 1454